Decipher Urologic Cancers Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 92

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $600M

Decipher Urologic Cancers General Information

Description

Developer of genomic tests designed to improve cancer patient care and outcomes. The company's platform is a clinically annotated genomic expression database for urological cancers, enabling the medical community and cancer patients to optimally access an assessment of tumor aggressiveness based on their unique genomic profile.

Contact Information

Formerly Known As
GenomeDx Biosciences, GenomeDx, Decipher Biosciences
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 10355 Science Center Drive
  • Suite 240
  • San Diego, CA 92121
  • United States
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Parent Company
Vertical(s)
Corporate Office
  • 10355 Science Center Drive
  • Suite 240
  • San Diego, CA 92121
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Decipher Urologic Cancers Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 12-Mar-2021 $600M Completed Generating Revenue
13. IPO 19-Jan-2021 Cancelled Generating Revenue
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC 26-May-2020 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
9. Later Stage VC 10-Apr-2019 Completed Generating Revenue
8. Later Stage VC (Series E) 05-Oct-2018 Completed Generating Revenue
7. Later Stage VC 27-Jun-2017 Completed Generating Revenue
6. Later Stage VC (Series C) 09-Mar-2016 $33.2M $63.8M Completed Generating Revenue
5. Debt - General 28-Sep-2015 $30M $30.5M Completed Generating Revenue
To view Decipher Urologic Cancers’s complete valuation and funding history, request access »

Decipher Urologic Cancers Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genomic tests designed to improve cancer patient care and outcomes. The company's platform is a clinically
Diagnostic Equipment
San Diego, CA
92 As of 2021

Birmingham, AL
 

Richmond Hill, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Decipher Urologic Cancers Competitors (29)

One of Decipher Urologic Cancers’s 29 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CirculoGene Venture Capital-Backed Birmingham, AL
StageZero Life Sciences Corporation Richmond Hill, Canada
Foundation Medicine Formerly VC-backed Boston, MA
Boreal Genomics Formerly VC-backed Vancouver, Canada
Nucleix Venture Capital-Backed Rehovot, Israel
You’re viewing 5 of 29 competitors. Get the full list »

Decipher Urologic Cancers Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Decipher Urologic Cancers Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albany Capital (Australia) Venture Capital Minority
Baird Capital PE/Buyout Minority
CD-Venture Venture Capital Minority
Calibrium (Zurich) Family Office Minority
EMBL Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Decipher Urologic Cancers FAQs

  • When was Decipher Urologic Cancers founded?

    Decipher Urologic Cancers was founded in 2008.

  • Where is Decipher Urologic Cancers headquartered?

    Decipher Urologic Cancers is headquartered in San Diego, CA.

  • What is the size of Decipher Urologic Cancers?

    Decipher Urologic Cancers has 92 total employees.

  • What industry is Decipher Urologic Cancers in?

    Decipher Urologic Cancers’s primary industry is Diagnostic Equipment.

  • Is Decipher Urologic Cancers a private or public company?

    Decipher Urologic Cancers is a Private company.

  • What is the current valuation of Decipher Urologic Cancers?

    The current valuation of Decipher Urologic Cancers is .

  • What is Decipher Urologic Cancers’s current revenue?

    The current revenue for Decipher Urologic Cancers is .

  • How much funding has Decipher Urologic Cancers raised over time?

    Decipher Urologic Cancers has raised $106M.

  • Who are Decipher Urologic Cancers’s investors?

    Albany Capital (Australia), Baird Capital, CD-Venture, Calibrium (Zurich), and EMBL Ventures are 5 of 12 investors who have invested in Decipher Urologic Cancers.

  • Who are Decipher Urologic Cancers’s competitors?

    CirculoGene, StageZero Life Sciences, Foundation Medicine, Boreal Genomics, and Nucleix are some of the 29 competitors of Decipher Urologic Cancers.

  • When was Decipher Urologic Cancers acquired?

    Decipher Urologic Cancers was acquired on 12-Mar-2021.

  • Who acquired Decipher Urologic Cancers?

    Decipher Urologic Cancers was acquired by Veracyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process